The introduction of anti-vascular endothelial growth factor (VEGF) agents into ophthalmology has revolutionized the treatment of many disease processes. Therefore, interest in more widespread ...

A prospective non-masked controlled study that included bilateral cases of 12 patients (24 eyes) with recurrent (had previous glaucoma surgery before) pediatric glaucoma. One eye in each patient (12 ...

Please provide your email address to receive an email when new articles are posted on . Subconjunctival injection of bevacizumab may enhance IOP-lowering effects of primary deep sclerectomy without ...

As an augmentation agent for primary deep sclerectomy, subconjunctival bevacizumab may enhance the IOP-lowering effects of the procedure without the bleb complications that can accompany surgery with ...